company logo

Director, Sales Operations at Agios Pharmaceuticals in Cambridge, MA

Save

compensation:

$200K — $250K *

specialty:

Sales Management & Operations, Sales

experience:

8 - 10 years

Job Description

See More

Valid through: 12/16/2020

About Agios Pharmaceuticals

Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.:Table 1 In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios. In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments. In April 2017, the company raised $250 million in a new stock offering in anticipation of FDA approval for its first cancer drug. In December 2017, the company filed a new drug application, or NDA, with the U.S. Food and Drug Administration, or FDA, for Ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia, or R/R AML with an IDH1 mutation. In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds. As of April 2017, Agios' CEO was David Schenkein. Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
stats icon
Total Jobs:
25
stats icon
Average Pay:
$126,034
stats icon
Total value of jobs:
$3,655,000
stats icon
% Masters:
60%
Learn More About Agios Pharmaceuticals view all icon
* Ladders Estimates

More Jobs at Agios Pharmaceuticals

Similar Jobs

More Pharmaceuticals & Biotech Jobs

RWE Data Scientist

$150K — $160K

5 days ago

Find similar Director, Sales Operations jobs: